<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Cholesterol lowering in patients with above-average cholesterol levels has been shown to reduce the progression of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We assess the effects of <z:chebi fb="23" ids="18059">lipid</z:chebi> lowering therapy on the progression of early, preintrusive carotid arterial <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> in high risk patients with <z:e sem="disease" ids="C0694546" disease_type="Disease or Syndrome" abbrv="">familial hyperlipidaemia</z:e> free of symptomatic <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Fifty-two patients with <z:e sem="disease" ids="C0694546" disease_type="Disease or Syndrome" abbrv="">familial hyperlipidaemia</z:e> by were treated by diet and various hypolipidaemic drugs </plain></SENT>
<SENT sid="3" pm="."><plain>Eighteen individuals were not taking hypolipidaemic drugs </plain></SENT>
<SENT sid="4" pm="."><plain>In a prospective study by B-mode ultrasound we assessed the intima-media thickness of the distal common carotid arterial (CCA) far wall at baseline and after 4 years </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In a subgroup of 25 patients with <z:e sem="disease" ids="C0020445" disease_type="Disease or Syndrome" abbrv="">familial hypercholesterolaemia</z:e> there was a significant decrease in total and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> and reduction in the intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) of the common carotid artery from 0.78+/-0.22 mm to 0.69+/-0.17 mm (p=0.004) </plain></SENT>
<SENT sid="6" pm="."><plain>In a subgroup of 27 patients with <z:e sem="disease" ids="C0020474,C1704417" disease_type="Disease or Syndrome" abbrv="">familial combined hyperlipidaemia</z:e> significant decreases in total and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> were associated with a decrease in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of common carotid. artery from 0.72+/-0.22 mm to 0.67+/-0.15 mm (p=0.044) </plain></SENT>
<SENT sid="7" pm="."><plain>In 18 individuals, who were not taking hypolipidaemic drugs, there were no significant changes in the levels of cholesterol and <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the common carotid artery (increase from 0.58+/-0.18 mm to 0.62+/-0.13 mm, p&gt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:chebi fb="23" ids="18059">Lipid</z:chebi>-lowering therapy in patients with <z:e sem="disease" ids="C0694546" disease_type="Disease or Syndrome" abbrv="">familial hyperlipidaemia</z:e> free of symptomatic <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> reverses the progression of early, preintrusive <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> of the carotid artery </plain></SENT>
<SENT sid="9" pm="."><plain>It is a beneficial sign indicating the possibility for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> regression </plain></SENT>
</text></document>